InsidersTradesSigma
Novo Integrated Sciences, Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Novo Integrated Sciences, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Novo Integrated Sciences, Inc. has recorded 1 insider filings. Market capitalisation: €1,267.8bn. The latest transaction was disclosed on 21 April 2022 (Acquisition). Among the most active insiders: Oliva Robert Letterio. Every trade is free.
1
Insider Decl.
0
Thresholds
€10,306
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Novo Integrated Sciences, Inc. Hold (neutral), based on 23 analysts. Average price target: US$307.99.
26Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 21 April 2022
Declarations1 total
5,000 shares@ US$2.2250.0000% mcap100.0% of flowCommon StockSEC:0001493152-22-010621:0
Ideal exit: 14 Jan 2023 (T+270)
1 of 1 declaration